{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"fanconi-anemia-complementation-group-d1","columns":[{"gene":"","key":"population-4f0c27d72cbd2c4dac4f","label":"Fanconi anemia, complementation group D1","mondoId":"MONDO:0011584","onsetQualifier":null,"originColumnKey":"MONDO:0011584/OMIM:605724","originalViews":[{"key":"MONDO:0011584/OMIM:605724","label":"Fanconi anemia, complementation group D1","scopeLabel":"OMIM:605724","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["00d0c6d46d065adab8fb159f6083ae079d4caefa14d6b2bb9aa5bbeec6bad0d7","016b99df0ce03a501c574da33e667b0989f0560f0e397673062c05daf96a0e88","1881f04e43ca0bf7ebcc6e9042301ae8515487a2ebff9176c5ca7adc2b0c4c74","2b2a6cef98995c682c1bb9fb3dd27fb7c9c4cd86582fe7583e5779deb9a034db","736de88cbdafcad8abd366687851b775c113b19bf7efbf404abc56243ed51d2b","944d0003828584165b23d8d009b62fb496565ffde8cb16706a130d6df994a424","a346fe61e2bb238c6c44c405e20cef9735d5a2a84ffc96a8d817a68d00cee09c","abc4ac08accdbf9830d22f9111b673f4c091819cffb100a260d658ce941f4812","c1d2353f64d43ff28067d98d591ded640c622086bae375f5512c57b1c7fae05f","de2b5234386dd660029788247b576172c1c6464d55828f80ede1d00d834f1cec","e8cca4543a715da8a49627a06d93e4212b8cfd4ca59853e5bf78e4f086424b6a"],"recordQualifiers":{},"scopeLabel":"OMIM:605724","sourceIds":["OMIM:605724"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-4f0c27d72cbd2c4dac4f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0004808","HP:0002023","HP:0005528","HP:0000957","HP:0003221","HP:0001508","HP:0001511"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":8,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"omim":2,"published":9}},"features":[{"hpoId":"HP:0004808","label":"Acute myeloid leukemia","primary":true},{"hpoId":"HP:0002023","label":"Anal atresia","primary":true},{"hpoId":"HP:0005528","label":"Bone marrow hypocellularity","primary":true},{"hpoId":"HP:0000957","label":"Cafe-au-lait spot","primary":true},{"hpoId":"HP:0003221","label":"Chromosomal breakage induced by crosslinking agents","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0001511","label":"Intrauterine growth retardation","primary":true},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false},{"hpoId":"HP:0009778","label":"Short thumb","primary":false},{"hpoId":"HP:0006727","label":"T-cell acute lymphoblastic leukemias","primary":false}],"ledeHtml":"Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations is a rare cancer-predisposing syndrome, associated with the D1 subgroup of Fanconi anemia (FA), characterized by progressive bone marrow failure, cardiac, brain, intestinal or skeletal abnormalities and predisposition to various malignancies. Bone marrow suppression and the incidence of developmental abnormalities are less frequent than in other FA, but cancer risk is very high with the spectrum of childhood cancers including Wilms tumor, brain tumor (often medulloblastoma) and ALL/AML.","mondoId":"MONDO:0011584","node":{"canonicalSlug":"fanconi-anemia-complementation-group-d1","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Fanconi anemia complementation group D1","originalSourceId":"ORPHA:319462","paragraphs":["Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations is a rare cancer-predisposing syndrome, associated with the D1 subgroup of Fanconi anemia (FA), characterized by progressive bone marrow failure, cardiac, brain, intestinal or skeletal abnormalities and predisposition to various malignancies. Bone marrow suppression and the incidence of developmental abnormalities are less frequent than in other FA, but cancer risk is very high with the spectrum of childhood cancers including Wilms tumor, brain tumor (often medulloblastoma) and ALL/AML."],"rawAttribution":"MONDO:0011584","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:24Z","upstream":"MONDO:0011584","url":"https://rarediseases.info.nih.gov/diseases/17449"},"ownColumnKeys":["population-4f0c27d72cbd2c4dac4f"],"publication":"published","relationships":[{"kind":"parent","label":"Fanconi anemia","mondoId":"MONDO:0019391","slug":"fanconi-anemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"count","key":"00d0c6d46d065adab8fb159f6083ae079d4caefa14d6b2bb9aa5bbeec6bad0d7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"PCS","frequency_raw":"1/7","hpo_id":"HP:0009778","is_excluded":false,"label":"Short thumb","onset_id":null,"reference":"PMID:15070707","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"016b99df0ce03a501c574da33e667b0989f0560f0e397673062c05daf96a0e88","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"OMIM:605724","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1881f04e43ca0bf7ebcc6e9042301ae8515487a2ebff9176c5ca7adc2b0c4c74","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0005528","is_excluded":false,"label":"Bone marrow hypocellularity","onset_id":null,"reference":"OMIM:605724","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"2b2a6cef98995c682c1bb9fb3dd27fb7c9c4cd86582fe7583e5779deb9a034db","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0002023","is_excluded":false,"label":"Anal atresia","onset_id":null,"reference":"PMID:15070707","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"736de88cbdafcad8abd366687851b775c113b19bf7efbf404abc56243ed51d2b","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0001511","is_excluded":false,"label":"Intrauterine growth retardation","onset_id":null,"reference":"PMID:15070707","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"944d0003828584165b23d8d009b62fb496565ffde8cb16706a130d6df994a424","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"PMID:15070707","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a346fe61e2bb238c6c44c405e20cef9735d5a2a84ffc96a8d817a68d00cee09c","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"PCS","frequency_raw":"4/7","hpo_id":"HP:0000957","is_excluded":false,"label":"Cafe-au-lait spot","onset_id":null,"reference":"PMID:15070707","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"abc4ac08accdbf9830d22f9111b673f4c091819cffb100a260d658ce941f4812","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"PCS","frequency_raw":"3/7","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"PMID:15070707","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c1d2353f64d43ff28067d98d591ded640c622086bae375f5512c57b1c7fae05f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003221","is_excluded":false,"label":"Chromosomal breakage induced by crosslinking agents","onset_id":null,"reference":"PMID:15070707","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"de2b5234386dd660029788247b576172c1c6464d55828f80ede1d00d834f1cec","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0004808","is_excluded":false,"label":"Acute myeloid leukemia","onset_id":null,"reference":"PMID:15070707","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e8cca4543a715da8a49627a06d93e4212b8cfd4ca59853e5bf78e4f086424b6a","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:605724","disease_name":"Fanconi anemia, complementation group D1","evidence":"PCS","frequency_raw":"1/7","hpo_id":"HP:0006727","is_excluded":false,"label":"T-cell acute lymphoblastic leukemias","onset_id":null,"reference":"PMID:15070707","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17449\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011584\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0011584</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations is a rare cancer-predisposing syndrome, associated with the D1 subgroup of Fanconi anemia (FA), characterized by progressive bone marrow failure, cardiac, brain, intestinal or skeletal abnormalities and predisposition to various malignancies. Bone marrow suppression and the incidence of developmental abnormalities are less frequent than in other FA, but cancer risk is very high with the spectrum of childhood cancers including Wilms tumor, brain tumor (often medulloblastoma) and ALL/AML.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17449\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"fanconi-anemia-complementation-group-d1","sourceDocuments":[{"name":"GARD: Fanconi anemia complementation group D1","reviewed":null,"source_release":"2026-10-25T03:42:24Z","url":"https://rarediseases.info.nih.gov/diseases/17449"},{"name":"MONDO: Fanconi anemia complementation group D1","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011584"}],"sourceNote":"","synonyms":["FAD1","FANCD1","Fanconi anemia complementation group D1","Fanconi anemia, complementation group D1"],"takeawayHtml":"","title":"Fanconi anemia complementation group D1"},"schemaVersion":1}
